Virtual reality as a strategy for intra-operatory anxiolysis and pharmacological sparing in patients undergoing breast surgeries: the V-RAPS randomized controlled trial

This project will explore the use of virtual reality (VR) to reduce the need for sedative medication during breast surgeries performed under regional anesthesia. Currently, patients undergoing these procedures often receive intravenous sedative medication to ease anxiety, which can lead to complications like breathing problems or longer recovery times. VR immersion, which has already been shown to help reduce pain and anxiety in other medical settings, might offer a safer alternative by helping patients stay calm without as much medication. In this study, 100 adult patients will be randomly assigned to either a VR group or a control group. Both groups can use sedative medication as needed, but the VR group will also wear headsets offering immersive scenarios to help them relax during surgery; researchers will be able to measure how much sedative each patient uses, along with their comfort, satisfaction, and recovery times. If successful, this approach could benefit healthcare providers by reducing medication-related risks, improving patient experiences, and potentially lowering recovery times. For the partner organization, this study could provide valuable insight into the optimization of VR technology for intra-operative use, based both on clinical outcomes and patient satisfaction data.

Faculty Supervisor:

Pascal Laferrière-Langlois;Louis Morisson

Student:

Partner:

Paperplane Therapeutics inc.

Discipline:

Life Sciences

Sector:

Retail trade

University:

Université de Montréal

Program: